Showing results (41-50 of 145) with videos related to
Sort By:
Pageof 15
International Journal of Experimental Pathology|September 11, 2018
Adaptive growth changes in the liver remnant are affected by the size of hepatectomy in ratsMichelle Meier, Kasper Jarlhelt Andersen, Anders Riegels Knudsen, et al.Ugeskrift for Laeger|July 11, 2017
[Non-alcoholic fatty liver disease in children and adolescents]Jessica Björklund, Tea Lund Laursen, Konstantin Kazankov, et al.Cancers|October 26, 2024
Impact of the Immune Landscape in Follicular Lymphoma: Insights into Histological Transformation in the Rituximab EraMarie Hairing Enemark, Maja Lund Jensen, Maja Dam Andersen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2004
Tumor karyotype predicts clinical outcome in colorectal cancer patientsGeorgia Bardi, Claus Fenger, Bertil Johansson, et al.Diseases of the Colon and Rectum|April 26, 2008
Adenocarcinoma arising from the rectal stump eleven years after excision of an ileal J-pouch in a patient with ulcerative colitis: report of a caseMark E Pedersen, Hans B Rahr, Claus Fenger, et al.Case Reports in Oncology|April 30, 2013
Advanced hepatocellular carcinoma in adolescence associated with congenital cholestasis: a case descriptionMorten Ladekarl, Gerda Elisabeth Villadsen, Anne Roed Rudbeck, et al.The American Journal of Pathology|October 28, 2003
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomasBirgitte Vrou Offersen, Boye Schnack Nielsen, Gunilla Høyer-Hansen, et al.Plos One|May 23, 2020
Glycolytic biomarkers predict transformation in patients with follicular lymphomaIda Monrad, Charlotte Madsen, Kristina Lystlund Lauridsen, et al.Nature Genetics|December 7, 2002
Identifying distinct classes of bladder carcinoma using microarraysLars Dyrskjøt, Thomas Thykjaer, Mogens Kruhøffer, et al.Acta Oncologica (Stockholm, Sweden)|November 22, 2018
Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: a Danish population-based nested case-control studyCathrine F Hjorth, Anja S Nielsen, Henrik T Sørensen, et al.Pageof 15